The Ureteral Stents Market, estimated at USD 586.5 Mn in 2025, is expected to exhibit a CAGR of 5.6% and reach USD 858.8 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Manufacturers in the ureteral stents market are engaged in product developments and technological innovations which is expected to drive the global ureteral stents market growth. Additionally, increasing focus of physicians towards minimally invasive treatment of ureteral stricture is a major reason driving growth of the market. For instance, C-Flex Double Pigtail Ureteral Stent product from Cook Medical is used for temporary internal drainage from the ureter pelvic junction to the bladder. Some of the key players offering pigtail stents are Boston Scientific, Olympus Medical Corporation, SILMAG, UROMED, Coloplast Ltd, and C.R Bard. Increasing number of product developments and focus on product improvement are contributing significantly to the growth of the global ureteral stents market.
Global Ureteral stents Market– Impact of Coronavirus (COVID-19) Pandemic
The most recent pandemic is coronavirus (COVID-19) pandemic, which was initially detected on December 31, 2025, in Wuhan, China. COVID-19 was declared a pandemic by the World Health Organization on March 11, 2025. According to the World Health Organization's Coronavirus Illness (COVID-19) Epidemiological Update, coronavirus disease (COVID-19) caused approximately 517 million cases and 6,261,708 fatalities globally, till May 9, 2025.
Furthermore, COVID-19 pandemic is expected to have negative impact on the global ureteral stents market growth, owing to decreased number of surgeries during the COVID-19 pandemic. For instance, according to an article published by the National Center for Biotechnology Information, a set of databases providing access to biomedical and genomic information, in December 2025, the weekly rate of surgical procedures did not decrease significantly during week 1 of the COVID period (March 11, 2025–March 31, 2025) when compared to the equivalent period in 2025. However, it decreased by 78% by week 2 and by 83% by week 3 as compared to the equivalent period in 2025. This study was carried out in Ontario, Canada by utilizing health administrative data sets of all hospital-based, scheduled, and urgent surgical procedures.